Trefoil Therapeutics
PrivateLast Round
Series A
Extension
Mar 8, 2022
Total Funding Raised
$45.6M
Company Overview
Trefoil Therapeutics operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was a Series A Extension round in March 2022.
Trefoil Therapeutics is a biotechnology company that develops regenerative pharmacologic treatments for corneal diseases using engineered fibroblast growth factor-1 protein technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Trefoil Therapeutics Comparables
Compare Trefoil Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Emmecell | 85% | |
| ActualEyes, Inc. | 79% | |
| Alcon | 77% |
For institutional investors. Book with your work email.
Trefoil Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Mar 8, 2022 | ||||
| Series A | Jul 16, 2019 | ||||
| Series 1 | Jan 5, 2017 | ||||
| Grant | Oct 20, 2015 |
For institutional investors. Book with your work email.
Trefoil Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hatteras Venture Partners | Series A, Series 1 |
| Correlation Ventures | Series 1, Series A |
| InFocus Capital Partners | Series 1, Series A |
| National Eye Institute | Grant |
| Access Biotechnology | Series A |
| AJU IB Investment | Series 1, Series A |
| Solasta Ventures | Series 1, Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 20, 2026
Monthly visitors increased 78% MoM.
- Jan 5, 2017
$5.2M round led by Hatteras Venture Partners.
For institutional investors. Book with your work email.
Trefoil Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Trefoil Therapeutics's valuation, stock price, and market status.
Is Trefoil Therapeutics a public or private company?
Trefoil Therapeutics is a private company.
What is the current stock price of Trefoil Therapeutics?
Trefoil Therapeutics is a private company, so its shares have no public market price. Caplight tracks Trefoil Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Trefoil Therapeutics worth (valuation)?
Valuation information for Trefoil Therapeutics is not publicly available.
Can I buy Trefoil Therapeutics stock?
Trefoil Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Trefoil Therapeutics's last funding round?
Trefoil Therapeutics's most recent funding round was Series A Extension on March 8, 2022.
Who are the main investors in Trefoil Therapeutics?
Key investors in Trefoil Therapeutics include Hatteras Venture Partners, Bios Partners.
Will Trefoil Therapeutics IPO soon?
No public IPO plans have been announced for Trefoil Therapeutics.
How can I track Trefoil Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Trefoil Therapeutics's shares on secondary markets.